Rivaroxaban plasma levels in acute ischemic stroke and intracerebral hemorrhage.

Publication

Rivaroxaban plasma levels in acute ischemic stroke and intracerebral hemorrhage.

Journal Paper/Review - Mar 3, 2018

Seiffge David Julian, Kägi Georg, Michel Patrik, Fischer Urs, Béjot Yannick, Wegener Susanne, Zedde Marialuisa, Turc Guillaume, Cordonnier Charlotte, Sándor Peter S, Rodier Gilles, Zini Andrea, Cappellari Manuel, Schaedelin Sabine A, Polymeris Alexandros A, Werring David J, Thilemann Sebastian, Maestrini Ilaria, Berge Eivind, Traenka Christopher, Vehoff Jochen, De Marchis Gian Marco, Peters Nils, Sirimarco Gaia, Bonati Leo H, Arnold Marcel, Lyrer Philippe A, De Maistre Emmanuel, Luft Andreas R, Tsakiris Dimitrios A, Engelter Stefan T, Novel Oral Anticoagulants in Stroke Patients study group

Citation

Seiffge D, Kägi G, Michel P, Fischer U, Béjot Y, Wegener S, Zedde M, Turc G, Cordonnier C, Sándor P, Rodier G, Zini A, Cappellari M, Schaedelin S, Polymeris A, Werring D, Thilemann S, Maestrini I, Berge E, Traenka C, Vehoff J, De Marchis G, Peters N, Sirimarco G, Bonati L, Arnold M, Lyrer P, De Maistre E, Luft A, Tsakiris D, Engelter S, Novel Oral Anticoagulants in Stroke Patients study group. Rivaroxaban plasma levels in acute ischemic stroke and intracerebral hemorrhage. Ann Neurol 2018; 83:451-459.

Type

Journal Paper/Review (English)

Journal

Ann Neurol 2018; 83

Publication Date

Mar 3, 2018

Issn Electronic

1531-8249

Pages

451-459

Brief description/objective

Information about rivaroxaban plasma level (RivLev) may guide treatment decisions in patients with acute ischemic stroke (AIS) and intracerebral hemorrhage (ICH) taking rivaroxaban.